References
- Asplund K., Wiholm B. E., Lithner F. Glibenclamide-associated hypoglycaemia: a report on 57 cases. Diabetologia 1983; 24: 412–4171. Asplund K., Wiholm B. E., Lithner F. Glibenclamide-associated hypoglycaemia: a report on 57 cases. Diabetologia 1983; 24: 412–417
- Baba S., Nakagawa S., Takebe K., Goto Y., Maezawa H., Takeda R., Sakamoto N., Fukui I. (1982) Comparison of gliclazide and glibenclamide treatment in non-insulin dependent diabetics. 11th Congress of the International Diabetic Federation, Amsterdam, 1982. Exerpta Medica Oxford, Princeton, 8, (abstract)2. Baba S., Nakagawa S., Takebe K., Goto Y., Maezawa H., Takeda R., Sakamoto N., Fukui I. (1982) Comparison of gliclazide and glibenclamide treatment in non-insulin dependent diabetics. 11th Congress of the International Diabetic Federation, Amsterdam, 1982. Exerpta Medica Oxford, Princeton, 8, (abstract)
- Clarke B. F., Campbell I. W. Long term trial of glibenclamide and chlorpropamide in diet controlled, maturity onset diabetes. Lancet 1975; 1: 246–2483. Clarke B. F., Campbell I. W. Long term trial of glibenclamide and chlorpropamide in diet controlled, maturity onset diabetes. Lancet 1975; 1: 246–248
- Kadowaki T., Hagawa R., Kajinuma H., Kuzuya N., Yoshida S. Chlorpropamide induced hyponatraemia: incidence and risk factors. Diabetes Care 1983; 6: 468–4714. Kadowaki T., Hagawa R., Kajinuma H., Kuzuya N., Yoshida S. Chlorpropamide induced hyponatraemia: incidence and risk factors. Diabetes Care 1983; 6: 468–471
- Koss F. W., Kopitzar Z., Hammer R. The pharmacokinetic profile of glurenorm. Diabetol. Croat. 1976; 5: 355–3715. Koss F. W., Kopitzar Z., Hammer R. The pharmacokinetic profile of glurenorm. Diabetol. Croat. 1976; 5: 355–371
- Multi-Centre Study Group. U.K. prospective study of therapies of maturity onset diabetes. Diabetologia 1983; 24: 404–4116. Multi-Centre Study Group. U.K. prospective study of therapies of maturity onset diabetes. Diabetologia 1983; 24: 404–411
- Roth J., Muggeo M. Insulin receptors and hypoglycaemia. “Diabetes Mellitus”, H. Rifkin, P. Raskin. Brady, Bowie, Maryland 1981; Vol. 5: 63–777. Roth J., Muggeo M. Insulin receptors and hypoglycaemia. “Diabetes Mellitus”, H. Rifkin, P. Raskin. Brady, BowieMaryland 1981; Vol. 5: 63–77
- Shen S.-W., Bressler R. Clinical pharmacology of oral antidiabetic agents. N. Engl. J. Med. 1977; 296: 493–4978. Shen S.-W., Bressler R. Clinical pharmacology of oral antidiabetic agents. N. Engl. J. Med. 1977; 296: 493–497
- Waldhausl W. To flush or not to flush? Comments on the chlorpropamide-alcohol flush. Diabetologia 1984; 26: 12–149. Waldhausl W. To flush or not to flush? Comments on the chlorpropamide-alcohol flush. Diabetologia 1984; 26: 12–14